Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC).

被引：0
|
作者：
Swaminathan, Akshay [1 ]
Stergiopoulos, Stella [2 ]
Snider, Jeremy [1 ]
Fisher, Virginia [2 ]
Castellanos, Emily [1 ]
Snow, Tamara [1 ]
Cho-Phan, Cheryl [1 ]
Comment, Leah [2 ]
Cunningham, Rachel [2 ]
McCusker, Margaret E. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
[2] Fdn Med, Cambridge, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
864
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world challenges of EGFR mutation testing in advanced non-small cell lung cancer: complementary roles of next generation sequencing and Idylla
    Habran, L.
    Piron, H.
    Pisvin, S.
    Delvenne, P.
    VIRCHOWS ARCHIV, 2020, 477 : S41 - S41
  • [32] Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
    Yu, Tiffany M.
    Morrison, Carl
    Gold, Edward J.
    Tradonsky, Alison
    Arnold, Renee J. G.
    VALUE IN HEALTH, 2018, 21 (11) : 1278 - 1285
  • [33] Identification and use of treatment (tx) options in patients (pts) with advanced non-small cell lung cancer (aNSCLC) after comprehensive genomic profiling (CGP): A real-world study.
    Mascaux, Celine
    Bubendorf, Lukas
    Barlesi, Fabrice
    Clendening, James W.
    Zhang, Qing
    Mace, Kieran
    Gondos, Adam
    Foser, Stefan
    Wang, Lisa I.
    Paz-Ares, Luis G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations
    Stencel, Katarzyna
    Wasag, Bartosz
    Pruszko, Cezary
    Dabrowska, Krystyna
    Ksiazek, Pawel
    Dziadek, Karolina
    Bryl, Maciej
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 201 - 208
  • [35] Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor.
    Khozin, Sean
    Zhi, Jizu
    Jun, Monika
    Chen, Li
    Rubinstein, Wendy S.
    Walker, Mark S.
    Komatsoulis, George Anthony
    Roberts, Jeremy
    Fukushima, Ryan
    Lau, Denise
    Hyde, Brigham
    Stepanski, Edward
    Miller, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Use of next-generation sequencing (NGS) to study the impact of demographic variables on prevalence of driver mutations in non-small cell lung cancer (NSCLC).
    Choi, WonSeok William
    Haroun, Faysal
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Next-Generation Sequencing Implementation in Non-Small Cell Lung Cancer Molecular Diagnosis
    Clave, S.
    Bellosillo, B.
    Salido, M.
    Tagmouti, G.
    Taus, A.
    Rocha, P.
    Hardy-Werbin, M.
    Moliner, L.
    Riera, X.
    Fernandez-Rodriguez, C.
    Arriola, E.
    Pijuan, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S783 - S783
  • [38] Therapeutic strategy for non-small cell lung cancer in the next-generation sequencing era
    Hayashi, Ryuji
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 1 - 2
  • [39] Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Truini, A.
    Coco, S.
    Vanni, I.
    Alama, A.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 86 - 87
  • [40] The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancer
    Zhao, Chenglong
    Li, Jianghua
    Zhang, Yongchang
    Han, Rui
    Wang, Yubo
    Li, Li
    Zhang, Yimin
    Zhu, Mengxiao
    Zheng, Jie
    Du, Haiwei
    Hu, Chen
    Zhou, Chengzhi
    Yang, Nong
    Cai, Shangli
    He, Yong
    CANCER MEDICINE, 2023, 12 (05): : 5603 - 5614
12345